Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Claims for Patent: 8,486,925

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 8,486,925
Title:Testosterone gel and method of use
Abstract: The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
Inventor(s): Malladi; Ramana (Marietta, GA), Miller; Jodi (Marietta, GA)
Assignee: Unimed Pharmaceuticals, LLC (Abbott Park, IL) Laboratoires Besins International, SAS (Paris, FR)
Application Number:13/253,867
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,486,925
Patent Claims: 1. A hydroalcoholic gel consisting of: a) 1.62% (w/w) testosterone; b) 1.0% (w/w) isopropyl myristate; c) 73.5% (w/w) ethanol; d) 1.0% (w/w) of a polyacrylic acid; e) 7.0% (w/w) of 0.1 N sodium hydroxide; and f) water.

2. The hydroalcoholic gel of claim 1, wherein the ethanol is about 95% (v/v) ethanol.

3. The hydroalcoholic gel of claim 1, wherein the polyacrylic acid has been neutralized by combining 1.0% (w/w) of the polyacrylic acid with 7.0% (w/w) of the 0.1 N sodium hydroxide.

4. The hydroalcoholic gel of claim 1, wherein the polyacrylic acid is a carbomer.

5. The hydroalcoholic gel of claim 3, wherein the polyacrylic acid is a carbomer.

6. The hydroalcoholic gel of claim 1, wherein a therapeutically effective dose of the hydroalcoholic gel for treatment of hypogonadism in a human male is 2.5 grams.

7. The hydroalcoholic gel of claim 6, wherein the dose of testosterone administered by applying the therapeutically effective dose to the human male is 40.5 milligrams.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.